119 related articles for article (PubMed ID: 10070983)
21. [Pharma-clinics. The drug of the month. Celecoxib (Celebrex)].
Scheen AJ
Rev Med Liege; 2001 Jan; 56(1):53-5. PubMed ID: 11256140
[TBL] [Abstract][Full Text] [Related]
22. Celecoxib for rheumatoid arthritis.
Megeff CE; Strayer SM
J Fam Pract; 2000 Feb; 49(2):108-9. PubMed ID: 10718683
[No Abstract] [Full Text] [Related]
23. Cyclooxygenase-2 enzyme inhibitors: place in therapy.
Noble SL; King DS; Olutade JI
Am Fam Physician; 2000 Jun; 61(12):3669-76. PubMed ID: 10892637
[TBL] [Abstract][Full Text] [Related]
24. Selective cyclooxygenase-2 inhibitors for the treatment of arthritis.
Fung HB; Kirschenbaum HL
Clin Ther; 1999 Jul; 21(7):1131-57. PubMed ID: 10463513
[TBL] [Abstract][Full Text] [Related]
25. [Current post-marketing information. Effects and adverse effects of celecoxib].
Schmidt H; Geisslinger G
Pharm Unserer Zeit; 2002; 31(2):180-7. PubMed ID: 11977454
[No Abstract] [Full Text] [Related]
26. The pain game.
Wadman M
Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159
[No Abstract] [Full Text] [Related]
27. Are rofecoxib and celecoxib safer NSAIDS?
Drug Ther Bull; 2000 Nov; 38(11):81-6. PubMed ID: 11138599
[TBL] [Abstract][Full Text] [Related]
28. The COX-2 inhibitors--an update.
Furberg CD
Am Heart J; 2006 Aug; 152(2):197-9. PubMed ID: 16875896
[No Abstract] [Full Text] [Related]
29. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered].
MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036
[No Abstract] [Full Text] [Related]
30. [Cox-2 inhibitors in the focus. Rofecoxib as effective as the "classics"].
MMW Fortschr Med; 2001 Nov; 143(46):50-1. PubMed ID: 11759601
[No Abstract] [Full Text] [Related]
31. Balancing the risks and benefits of celecoxib.
Caldwell B; Beasley R; Weatherall M; Metcalfe S
Am J Med; 2007 Jun; 120(6):e17. PubMed ID: 17524734
[No Abstract] [Full Text] [Related]
32. NSAIDs, Helicobacter pylori, and Pandora's Box.
Graham DY
N Engl J Med; 2002 Dec; 347(26):2162-4. PubMed ID: 12501230
[No Abstract] [Full Text] [Related]
33. Pain management in patients with osteoarthritis.
Finucane TE
JAMA; 2003 Jul; 290(1):36; author reply 36. PubMed ID: 12837705
[No Abstract] [Full Text] [Related]
34. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results.
Tindall E
J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176
[TBL] [Abstract][Full Text] [Related]
35. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
Geis GS
Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
[TBL] [Abstract][Full Text] [Related]
36. Allergic vasculitis associated with celecoxib.
Jordan KM; Edwards CJ; Arden NK
Rheumatology (Oxford); 2002 Dec; 41(12):1453-5. PubMed ID: 12468830
[No Abstract] [Full Text] [Related]
37. Researchers plan to continue to study COX-2 inhibitors in cancer treatment and prevention.
Vanchieri C
J Natl Cancer Inst; 2005 Apr; 97(8):552-3. PubMed ID: 15840872
[No Abstract] [Full Text] [Related]
38. Persistence with COX-2 inhibitors in managed care: an analysis of claims data.
Harley C; Wagner S
Manag Care Interface; 2003 Oct; 16(10):38-45. PubMed ID: 14606259
[TBL] [Abstract][Full Text] [Related]
39. FDA approves first celecoxib generics.
Kuehn BM
JAMA; 2014 Jun; 311(24):2470. PubMed ID: 25058066
[No Abstract] [Full Text] [Related]
40. Use of nimesulide in children.
Addis A; Bonati M
Lancet; 1999 Sep; 354(9183):1034. PubMed ID: 10501394
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]